ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 355461 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 355461; 2) Community: the network communities that were significantly associated with the response to NSC 355461; 3) Molecule: the relationships between components within communities and NSC 355461; 4) MDR: the compounds that were significantly associated with the NSC 355461.

NSC Compound Enrichment Correlation
NSC 76519 Inosine, 6-thio-, 2',3',5'-tris(4-methoxybenzoate) 0.0273093708703115 -0.087141395
NSC 80141 Null 0.0273093708703115 0.10920454
NSC 85700 Quinolinium, 2-[2-(8-hydroxy-5-quinolyl)vinyl]-1,6-methyl-, iodide (8CI) 0.0273093708703115 0.25140164
NSC 9609 Janus Red B 0.0273093708703115 0.34802112
NSC 123491 L-Cysteine, S-[tris(4-methylphenyl)methyl]- (9CI) 0.0287337488682928 0.20563711
NSC 19441 FDA 0283 0.0287337488682928 0.13831297
NSC 210717 Ellipticine, 9-hydroxy-, hydrochloride 0.0287337488682928 0.13247438
NSC 59620 (4a,6a,9-trimethyl-6,7-dioxo-2,3,4,4b,5,6b,10,10a,11,11a,11b,12,13,13a-tetradecahydro-1H-indeno[2,1-a]phenanthren-2-yl) acetate 0.0287337488682932 0.17933646
NSC 658292 Null 0.0287337488682932 0.047997829
NSC 658425 Null 0.0287337488682932 0.48227386
Total:57  Current:36    [First] [Prev] [Next] [Last]